Tech Alert: Targeted compliance reviews – Vitamin D & bone indications 

The TGA will be conducting targeted compliance reviews of selected listed medicines that contain colecalciferol (Vitamin D) and bone related indications, beginning Oct/Nov 2022. The review does not  include review of products that contain vitamin D and calcium.

This technical alert provides more information for sponsors, including additional contextual information on studies that may have informed the review, and comparable international perspectives. 

LinkedIn
Facebook
Twitter
Email

RECENT ARTICLES

Vale Stephen Myers

It is with great sadness that we learned of the passing of Emeritus Professor Stephen Myers late last week. Stephen was a giant in the

Read More